
XORTX Provides Corporate Update
● Synopsis of 2020 Achievements and Key Activities for 2021 ●
CALGARY, Alberta, Jan. 19, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide a synopsis of 2020 achievements and guidance on key activities for 2021.
› Read more